BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25692079)

  • 1. The mythical concept and untoward consequences of a diagnosis of dysplastic nevus: an overdue tribute to A. Bernard Ackerman, MD.
    Hurwitz RM; Tavel ME
    Dermatol Pract Concept; 2015 Jan; 5(1):31-4. PubMed ID: 25692079
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic changes in different types of melanocytic nevi. A unifying concept.
    Toussaint S; Kamino H
    J Cutan Pathol; 1999 Feb; 26(2):84-90. PubMed ID: 10082398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
    Xavier-Junior JCC; Ocanha-Xavier JP
    Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Nevus-Associated Melanoma with Common or Dysplastic Melanocytic Nevus: A Systematic Review and Meta-Analysis.
    Dessinioti C; Befon A; Stratigos AJ
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765817
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatoscopy of "dysplastic nevi": a beacon in diagnostic darkness.
    Roesch A; Burgdorf W; Stolz W; Landthaler M; Vogt T
    Eur J Dermatol; 2006; 16(5):479-93. PubMed ID: 17101467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic reassessment of melanoma and other melanocytic skin lesions excised in 2009 and 2018-2019.
    Gjersvik P; Veierød MB; Thompson A; Grzyb K; Liland KH; Vazov N; Roscher I; Bassarova AV
    Tidsskr Nor Laegeforen; 2022 Oct; 142(15):. PubMed ID: 36286556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?
    Roesch A; Landthaler M; Vogt T
    Hautarzt; 2003 Sep; 54(9):871-83; quiz 884-5. PubMed ID: 14575036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer.
    Ackerman AB
    Histopathology; 1988 Sep; 13(3):241-56. PubMed ID: 3056824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogenesis of cutaneous malignant melanoma: The vast majority do not develop from melanocytic nevus but arise de novo as melanoma in situ.
    Saida T
    J Dermatol; 2019 Feb; 46(2):80-94. PubMed ID: 30632197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplastic nevus: Fact and fiction.
    Rosendahl CO; Grant-Kels JM; Que SK
    J Am Acad Dermatol; 2015 Sep; 73(3):507-12. PubMed ID: 26037217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes.
    Wakefield C; O'Keefe L; Heffron CCBB
    Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dysplastic melanocytic nevus].
    Bierhoff E
    Pathologe; 2015 Feb; 36(1):46-50, 52. PubMed ID: 25591417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.